Share

Latest Documents


  • 26-September-2014

    English

    Test No. 474: Mammalian Erythrocyte Micronucleus Test

    The mammalian in vivo micronucleus test is used for the detection of damage induced by the test substance to the chromosomes or the mitotic apparatus of erythroblasts, by analysis of erythrocytes as sampled in bone marrow and/or peripheral blood cells of animals, usually rodents (mice or rats).The purpose of the micronucleus test is to identify substances (liquid or solid) that cause cytogenetic damage which results in the formation of micronuclei containing lagging chromosome fragments or whole chromosomes. An increase in the frequency of micronucleated polychromatic erythrocytes in treated animals is an indication of induced chromosome damage. Animals are exposed to the test substance by an appropriate route (usually by gavage using a stomach tube or a suitable intubation cannula, or by intraperitoneal injection). Bone marrow and/or blood cells are collected, prepared and stained. Preparations are analyzed for the presence of micronuclei. Each treated and control group must include at least 5 analysable animals per sex. Administration of the treatments consists of a single dose of test substance or two daily doses (or more). The limit dose is 2000 mg/kg/body weight/day for treatment up to 14 days, and 1000 mg/kg/body weight/day for treatment longer than 14 days.
  • 26-September-2014

    English

    Test No. 475: Mammalian Bone Marrow Chromosomal Aberration Test

    The mammalian in vivo chromosome aberration test is used for the detection of structural chromosome aberrations induced by test compounds in bone marrow cells of animals, usually rodents (rats, mice and Chinese hamsters). Structural chromosome aberrations may be of two types: chromosome or chromatid.Animals are exposed to the test substance (liquid or solid) by an appropriate route of exposure (usually by gavage using a stomach tube or a suitable intubation cannula, or by intraperitoneal injection) and are sacrificed at appropriate times after treatment. Prior to sacrifice, animals are treated with a metaphase-arresting agent. Chromosome preparations are then made from the bone marrow cells and stained, and metaphase cells are analysed for chromosome aberrations. Each treated and control group must include at least 5 analysable animals per sex. The limit dose is 2000 mg/kg/body weight/day for treatment up to 14 days, and 1000 mg/kg/body weight/day for treatment longer than 14 days.
  • 3-September-2014

    English

    Guidance Document on Standardised Test Guidelines for Evaluating Chemicals for Endocrine Disruption

    This document is a tool to support regulatory authorities’ decisions on the hazard of specific chemicals when they receive test results from a Test Guideline (TG) or draft TG for the screening/testing of chemicals for endocrine disrupting properties. The contexts for these decisions will vary, depending on local legislation and practice, so the advice is worded in such a way as to permit flexible interpretation. It provides guidance on how to interpret the outcome of individual tests and how to increase evidence on whether or not a substance may be an endocrine disrupter; to this end, it recommends a test method that may be performed if regulatory authorities need more evidence.
  • 18-July-2014

    English

    Guidance document on an integrated approach on testing and assessment (IATA) for skin corrosion and irritation

    This guidance document proposes an integrated approach on testing and assessment for skin corrosion and irritation, in view of replacing the "testing and evaluation strategy" provided in the supplement to OECD TG404 (to be updated), provides information on key performance characteristics of each information source comprising the IATA, and guidance on how to integrate information for decision making for classification and labeling.

    Related Documents
  • 31-August-2013

    English

    Presentation by Endpoints: Section 2 - Effects on Biotic Systems

    Presentation by Endpoints: Section 2 - Effects on Biotic Systems

    Related Documents
  • 12-August-2013

    English

    Test Guidelines: Updates

    On 26 July 2013, the OECD Council adopted three new, six updated and one corrected OECD Test Guidelines for the testing of chemicals, as well as a new Introduction to the Section 5, Part A on Pesticides Residue Chemistry.

    Related Documents
  • 1-August-2013

    English

    Guidance for Assessment of the Efficacy of Baits Against Garden Ants

    This biocide document provides guidance on the conduct of laboratory and field tests aimed to assess the efficacy of anti-ants baits for indoor use. A bait contains one or more insecticidal active ingredients combined with food for garden ants.

    Related Documents
  • 26-June-2013

    English

    OECD Guidance Document on Quantitative Methods for Evaluating the Activity of Microbicides used on Hard Non-Porous Surfaces

    This document describes four quantitative methods for efficacy evaluation: bactericidal, mycobactericidal, fungicidal and virucidal. Regulatory authorities have relied upon efficacy data generated using these methods to authorise the placing of biocidal products on the market.

    Related Documents
  • 29-May-2013

    English

    OECD Guidance Document on Standardised Test Guidelines for Evaluating Chemicals for Endocrine Disruption

    The objective of the Guidance Document is to provide guidance on how to interpret the outcome of individual tests and how to increase evidence on whether or not a substance may be an endocrine disrupter. However, testing strategies or guidance on interpretation from a suite of tests are not given.

    Related Documents
  • 31-January-2013

    English, PDF, 101kb

    Update of Test Guidelines and the Mutual Acceptance of Data

    In 2012, the Joint Meeting agreed on the status of deleted and former versions of Test Guidelines with regards to the Mutual Acceptance of Data (MAD). An 18-month transitional period between the Council Decision and the effective date of deletion was agreed, after which no new test using the deleted or the former version of a Test Guideline can be initiated.

    Related Documents
  • << < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 > >>